Back

Mortality and readmission in non-ischemic compared with ischemic cardiomyopathies after implantable cardioverter-defibrillator implantation

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Device Therapy ePosters Implantable Cardioverter-Defibrillator (ICD) ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor James Freeman

Yale School of Medicine, New Haven (United States of America)

56 More presentations in this session

Presentation thumbnail
Pacemakers capable of monitoring sleep-disordered breathing: impact on sleep apnea detection in real life
Doctor N. Bidegain (Pau, FR)
Abstract Slides
Presentation thumbnail
Device-device communication stability of leadless anti-tachycardia pacemaker and subcutaneous implantable cardioverter defibrillator over 18 months
Doctor F. Tjong (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
The back-up lead in his bundle pacing: evolution over the years
Doctor F. Zanon (Rovigo, IT)
Abstract Slides
Presentation thumbnail
Leadless pacemaker implant in patients with a history of open heart surgery: experience with the Micra transcatheter pacemaker
Doctor C. Garweg (Leuven, BE)
Abstract Slides
Presentation thumbnail
The challenge of education in conduction system pacing: results from single or dual operators.
Doctor F. Zanon (Rovigo, IT)
Abstract Slides

Access the full session

Session thumbnail
Device Therapy ePosters

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Session
Debate on primary prevention in ICD therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources